Real-time enrollment status for this high-grade serous ovarian carcinoma (hgsoc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:48 AM UTC
| NCT Number | NCT06476808 |
| Recruiting Status | Recruiting |
| Condition | High-grade Serous Ovarian Carcinoma (HGSOC) |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | April 15, 2026 (Apr 15, 2026) |
As of July 13, 2026: Clinical trial NCT06476808 is currently recruiting participants. This clinical trial study for high-grade serous ovarian carcinoma (hgsoc) is actively seeking new participants at 6 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06476808 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06476808 was last updated Apr 15, 2026 (April 15, 2026). HelloStudys verifies this status automatically.